Press Releases

Company press releases and official corporate announcements.

A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.

Articles

24,464 total articles

All In FutureTech Alliance Inc. Launches New Digital Platform for Consumers and Businesses, Advancing Its AI-Enabled Global Services Strategy

All In FutureTech Alliance Inc. Launches New Digital Platform for Consumers and Businesses, Advancing Its AI-Enabled Global Services Strategy

All In FutureTech Alliance Inc. announced the launch of its AIFA Digital Service Platform, a bilingual AI-centered content and education hub designed to build long-term user engagement and progressively connect users to its education, workforce development, and global business services. The platform supports a dual digital strategy with the corpora…

Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting

Evaxion will present new immune data for personalized cancer vaccine EVX-01 at the SITC 2026 Annual Meeting

Evaxion A/S, a clinical-stage TechBio company listed on NASDAQ, will present new immune data from its phase 2 trial of the AI-designed personalized cancer vaccine EVX-01 combined with pembrolizumab at the SITC 2026 Annual Meeting. The data highlight systemic immunomodulatory effects and durable clinical responses in advanced melanoma patients, foll…

Hall Chadwick Acquisition Corp. and REEcycle Holdings, Inc. Announce Filing of Registration Statement on Form S-4 and Release Updated Investor Presentation

Hall Chadwick Acquisition Corp. and REEcycle Holdings, Inc. Announce Filing of Registration Statement on Form S-4 and Release Updated Investor Presentation

Hall Chadwick Acquisition Corp. (NASDAQ: HCAC) and REEcycle Holdings, Inc. have jointly filed a registration statement on Form S-4 with the SEC relating to their proposed business combination. The filing includes a preliminary proxy statement/prospectus for shareholder approval and outlines next steps in the transaction process including mailing de…

StoneX Group Inc. Acquires Integra Trading S.A.S., Establishing a Colombian Coffee Origination and Processing Platform

StoneX Group Inc. Acquires Integra Trading S.A.S., Establishing a Colombian Coffee Origination and Processing Platform

StoneX Group Inc. has signed a definitive agreement to acquire Integra Trading S.A.S., a Colombian coffee trading, exporting, and processing company. The acquisition, conducted through StoneX's Swiss trading entity, will enhance StoneX's physical commodities business by increasing its direct origination and processing footprint in Colombia, improvi…

Ruanyun Announces Preliminary Unaudited First-Half Fiscal 2027 Revenue in the Range of US$9.3 Million to US$9.5 Million

Ruanyun Announces Preliminary Unaudited First-Half Fiscal 2027 Revenue in the Range of US$9.3 Million to US$9.5 Million

Ruanyun Edai Technology Inc. expects its preliminary unaudited revenue for the first half of fiscal 2027 to be between $9.3 million and $9.5 million, significantly increasing from $0.37 million in the same period last year. This growth is primarily fueled by its Smart Campus Services business launched in September 2025, which accounts for over half…

Cycurion Regains Compliance with Nasdaq Bid Price Requirement

Cycurion Regains Compliance with Nasdaq Bid Price Requirement

Cycurion, Inc., a cybersecurity and AI solutions provider, announced it has regained compliance with Nasdaq's minimum bid price requirement following a 1-for-8 reverse stock split. The company’s stock has remained above the $1.00 threshold for over 10 consecutive trading days, preventing delisting and allowing continued trading under the ticker CYC…

Liberty Defense and Wadsworth Solutions Announce Sale of HEXWAVE™ Systems to Cleveland Hopkins International Airport

Liberty Defense and Wadsworth Solutions Announce Sale of HEXWAVE™ Systems to Cleveland Hopkins International Airport

Liberty Defense Holdings Ltd. announced that Cleveland Hopkins International Airport will deploy two of its HEXWAVE systems to enhance the Aviation Worker Screening program. The AI-powered HEXWAVE system detects metallic and non-metallic threats using advanced millimeter wave technology and 3D imaging, providing comprehensive security screening. Wa…

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Autonomix Medical Strengthens Patent Protection for Platform Technology Enabling Precision Access, Treatment Delivery and Procedural Validation

Autonomix Medical announced issuance of Canadian Patent No. 3,183,802, which expands protection for their catheter-based transvascular intervention technologies that enable precise access, adaptive treatment delivery, and real-time procedural validation in nerve-targeted therapies. This patent complements existing U.S. and European patents, reinfor…

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

Century Therapeutics' CNTY-813 Demonstrates Continued Advancement Toward the Clinic Via Nonclinical Data Presented at EASD 2026

Century Therapeutics announced nonclinical data demonstrating effective glycemic control, scalable manufacturing, and successful engraftment of their iPSC-derived islet replacement therapy, CNTY-813. The company is on track to submit an IND in Q4 2026 and anticipates initial clinical data in the second half of 2027, highlighting advancements toward…

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

SCIENTURE Announces Arbli™ Added to Formularies at Three Leading U.S. Pediatric Academic Medical Centers and Hospitals

Scienture Holdings, Inc. announced that its proprietary oral suspension formulation of losartan, Arbli™, has been added to the formularies of three prominent U.S. pediatric academic medical centers. This milestone enhances Arbli's presence in the pediatric healthcare market. The product addresses a significant $219 million U.S. losartan market by o…

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

Journal of Child Neurology Publishes Review Highlighting Dopamine’s Role in Tourette Syndrome and Ecopipam’s Selective D1 Receptor Mechanism for Tourette Syndrome in Pediatric Patients

Teva Pharmaceuticals announced a comprehensive review published in the Journal of Child Neurology that details the role of dopamine in Tourette syndrome and presents ecopipam, an investigational selective D1 receptor antagonist, as a differentiated and potentially safer treatment for pediatric patients. Data from Phase 2 and 3 trials demonstrate ec…

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Teva Presents New Efficacy and Safety Data with Ecopipam, an Investigational Treatment for Pediatric Patients with Tourette Syndrome

Teva Pharmaceuticals disclosed new data demonstrating that ecopipam, their investigational treatment for pediatric Tourette syndrome, shows significant tic severity reduction in about 70% of patients within 8 weeks and sustained efficacy with no new safety concerns during long-term follow-up. The drug's efficacy is unaffected by common co-occurring…

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Hyperion DeFi Commences Share Buybacks, Retires All Legacy Debt, and Commits to Further Capital Optimization

Hyperion DeFi, Inc. announced repurchasing over 240,000 shares at a $3.21 average price, fully retiring $8.6 million of legacy debt, and positioning itself for further capital structure optimization. The company aims to leverage its debt-free status and $14.5 million in cash and equivalents to scale its Hyperliquid blockchain ecosystem and DeFi ope…

NETSOL Technologies appoints Michael Ramsey as Vice President of Sales for Asset Finance in the Americas

NETSOL Technologies appoints Michael Ramsey as Vice President of Sales for Asset Finance in the Americas

NETSOL Technologies, Inc. announced the appointment of Michael Ramsey as Vice President of Sales for its Transcend Finance platform in the Americas. Ramsey brings over 30 years of experience in asset finance enterprise sales and will lead growth initiatives in the U.S., the largest asset finance market globally. This strategic hire aligns with NETS…

Celcuity Appoints David Gryska To Its Board Of Directors

Celcuity Appoints David Gryska To Its Board Of Directors

Celcuity Inc., a biotechnology firm focused on targeted therapies for solid tumors, has appointed David Gryska to its Board of Directors. Mr. Gryska brings over 35 years of strategic and financial experience in life sciences, including CFO roles and board memberships at multiple biotech companies. This appointment comes as Celcuity transitions into…

Satellogic Announces Successful Launch of First Merlin Satellite

Satellogic Announces Successful Launch of First Merlin Satellite

Satellogic Inc. announced the successful launch of its first Merlin satellite along with additional NewSat satellites into low-Earth orbit, marking a significant milestone in deploying its Persistent Global Intelligence infrastructure. The Merlin satellite constellation will provide global detection and theater-scale monitoring with onboard AI proc…

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema

Surrozen, Inc. announced FDA clearance of its Investigational New Drug (IND) application for SZN-8141, a bifunctional Wnt agonist and VEGF antagonist, to treat diabetic macular edema (DME). This milestone enables initiation of the Phase 1b/2a DUET study expected in Q4 2026 and triggers the second closing of a private placement anticipated to raise …